Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users

Psychopharmacology

Volumn 216, Issue 4, 2011, Pages 545-556

  Burgess, Adrian P ^a   Venables, Louise ^b   Jones, Helena ^b   Edwards, Rhiannon ^b   Parrott, Andrew C ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Ecstasy; Event related potentials; MDMA; Memory; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; ANABOLIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; FLUOXETINE; KETAMINE; LYSERGIDE; OPIATE; SEROTONIN; SOLVENT;

ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LEFT HEMISPHERE; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MULTIPLE DRUG ABUSE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROSPECTIVE AND RETROSPECTIVE MEMORY QUESTIONNAIRE; RECOGNITION; SEROTONINERGIC SYSTEM; TASK PERFORMANCE; UPLIFTS HASSLES STRESSORS COGNITIVE FAILURES AND MEMORY PROBLEMS QUESTIONNAIRE; VISUAL MEMORY; WORD RECOGNITION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COGNITION; EVOKED POTENTIALS; FEMALE; HALLUCINOGENS; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RECOGNITION (PSYCHOLOGY); SEROTONIN; TIME FACTORS; YOUNG ADULT;

EID: 79961171493     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2249-9     Document Type: Article

References (39)

1. JP Aggleton MW Brown 2006 Interleaving brain systems for episodic and recognition memory Trends Cogn Sci 10 10 455 463 16935547 10.1016/j.tics.2006. 08.003 (Pubitemid 44415569)
2. M Arato E Frecska, et al. 1991 Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence Prog Neuropsychopharmacol Biol Psychiatry 15 6 759 764 1722341 10.1016/0278-5846(91)90004-K 1:CAS:528:DyaK38Xns1ykuw%3D%3D
3. AP Burgess JH Gruzelier 1997 Localization of word and face recognition memory using topographical EEG Psychophysiology 34 1 7 16 9009803 10.1111/j.1469-8986.1997.tb02410.x 1:STN:280:DyaK2s7mt12nsg%3D%3D (Pubitemid 27043807)
4. AP Burgess JH Gruzelier 2000 Short duration power changes in the EEG during recognition memory for words and faces Psychophysiology 37 5 596 606 11037036 10.1111/1469-8986.3750596 1:STN:280:DC%2BD3cvos1Grug%3D%3D
5. Burgess PW, Shallice T (1997) The relationship between prospective and retrospective memory: neuropsychological evidence. In: Conway, MA (ed) Cognitive models of memory. Cambridge MIT Press, Cambridge, pp 247-272
6. RJ Croft A Klugman, et al. 2001 Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users Am J Psychiatry 158 10 1687 1692 11579003 10.1176/appi.ajp.158.10.1687 1:STN:280:DC%2BD3MrjtF2nsQ%3D%3D (Pubitemid 32923663)
7. M Fink W Wadsak, et al. 2009 Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET Neuroimage 45 2 598 605 19103294 10.1016/j.neuroimage.2008.11.033
8. E Gouzoulis-Mayfrank J Daumann 2006 The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview J Psychopharmacol 20 2 188 193 16510477 10.1177/0269881106059939 1:CAS:528:DC%2BD28XjsFyjsbw%3D
9. E Gouzoulis-Mayfrank J Daumann 2009 Neurotoxicity of drugs of abuse-the case of methylenedioxyamphetamines (MDMA, ecstasy) and amphetamines Dialogues Clin Neurosci 11 3 305 317 19877498
10. AR Green AO Mechan, et al. 2003 The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Rev 55 3 463 508 12869661 10.1124/pr.55.3.3 1:CAS:528: DC%2BD3sXnsVynurs%3D (Pubitemid 37013213)
11. G Hatzidimitriou UD McCann, et al. 1999 Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4- methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery J Neurosci 19 12 5096 5107 10366642 1:CAS:528: DyaK1MXjvVGjurc%3D (Pubitemid 29270144)
12. CA Joyce KA Paller, et al. 1998 Memory changes with normal aging: behavioral and electrophysiological measures Psychophysiology 35 6 669 678 9844428 10.1111/1469-8986.3560669 1:STN:280:DyaK1M%2FmtVCiug%3D%3D (Pubitemid 28533599)
13. A Kafkas EM Migo 2009 Familiarity and recollection in the medial temporal lobe J Neurosci 29 8 2309 2311 19244507 10.1523/JNEUROSCI.5874-08.2009 1:CAS:528:DC%2BD1MXislWhtLk%3D
14. AD Kalechstein R De La Garza 2nd, et al. 2007 MDMA use and neurocognition: a meta-analytic review Psychopharmacology (Berl) 189 4 531 537 10.1007/s00213-006-0601-2 1:CAS:528:DC%2BD28Xht1entL7E (Pubitemid 44791222)
15. SJ Kish J Lerch, et al. 2010 Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study Brain 133 Pt 6 1779 1797 20483717 10.1093/brain/awq103
16. KR Laws J Kokkalis 2007 Ecstasy (MDMA) and memory function: a meta-analytic update Hum Psychopharmacol 22 6 381 388 17621368 10.1002/hup.857 (Pubitemid 47316122)
17. NJ Lobaugh R West, et al. 2001 Spatiotemporal analysis of experimental differences in event-related potential data with partial least squares Psychophysiology 38 3 517 530 11352141 10.1017/S0048577201991681 1:STN:280:DC%2BD3M3lsValug%3D%3D (Pubitemid 32422296)
18. G Mandler 1980 Recognizing: the judgment of previous occurrence Psychol Rev 87 3 252 271 10.1037/0033-295X.87.3.252
19. RH McAllister-Williams AE Massey, et al. 2002 Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval Psychopharmacology (Berl) 160 4 434 442 10.1007/s00213-001-0996-8 1:CAS:528:DC%2BD38XktFGhsbo%3D (Pubitemid 34253286)
20. D Mendelsohn WJ Riedel, et al. 2009 Effects of acute tryptophan depletion on memory, attention and executive functions: a systematic review Neurosci Biobehav Rev 33 6 926 952 19428501 10.1016/j.neubiorev.2009.03.006 1:CAS:528:DC%2BD1MXltFelsr8%3D
21. CJ Morgan L Muetzelfeldt, et al. 2010 Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study Addiction 105 1 121 133 19919593 10.1111/j.1360-0443. 2009.02761.x
22. RG Morris S Abrahams, et al. 1995 Recognition memory for words and faces following unilateral temporal lobectomy Br J Clin Psychol 34 Pt 4 571 576 8563663
23. CE Nulsen AM Fox, et al. 2010 Differential effects of ecstasy on short-term and working memory: a meta-analysis Neuropsychol Rev 20 1 21 32 20157852 10.1007/s11065-009-9124-z
24. SS O'Malley FH Gawin 1990 Abstinence symptomatology and neuropsychological impairment in chronic cocaine abusers NIDA Res Monogr 101 179 190 2092215
25. AC Parrott FJ Kaye 1999 Daily uplifts, hassles, stresses and cognitive failures: in cigarette smokers, abstaining smokers, and non-smokers Behav Pharmacol 10 6-7 639 646 10780505 10.1097/00008877-199911000-00010 1:STN:280:DC%2BD3c3ktFCitQ%3D%3D (Pubitemid 30026058)
26. AC Parrott RM Milani, et al. 2001 Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems Psychopharmacology (Berl) 159 1 77 82 10.1007/s002130100897 1:CAS:528:DC%2BD38XisVKlt7o%3D (Pubitemid 34031254)
27. AC Parrott T Buchanan, et al. 2002 Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users Hum Psychopharmacol 17 6 309 312 12404677 10.1002/hup.415 1:CAS:528:DC%2BD38XntF2js7c%3D
28. J Rodgers T Buchanan, et al. 2006 Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study J Psychopharmacol 20 3 437 446 16174668 10.1177/ 0269881105058777
29. G Rogers J Elston, et al. 2009 The harmful health effects of recreational ecstasy: a systematic review of observational evidence Health Technol Assess 13 6 1 315 iii-iv, ix-xii
30. MD Rugg T Curran 2007 Event-related potentials and recognition memory Trends Cogn Sci 11 6 251 257 17481940 10.1016/j.tics.2007.04.004 (Pubitemid 46809560)
31. BM Sayers HA Beagley, et al. 1974 The mechansim of auditory evoked EEG responses Nature 247 441 481 483 4818547 10.1038/247481a0 1:STN:280: DyaE2c7jtVSltw%3D%3D
32. T Schilt MW Koeter, et al. 2010 Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users Psychopharmacology (Berl) 207 4 583 591 10.1007/s00213-009-1688-z 1:CAS:528:DC%2BD1MXhsVOgtLnK
33. G Smith S Della Sala, et al. 2000 Prospective and retrospective memory in normal ageing and dementia: a questionnaire study Memory 8 5 311 321 11045239 10.1080/09658210050117735 1:STN:280:DC%2BD3crgtFSgsw%3D%3D
34. D Swick RT Knight 1997 Event-related potentials differentiate the effects of aging on word and nonword repetition in explicit and implicit memory tasks J Exp Psychol Learn Mem Cogn 23 1 123 142 9028023 10.1037/0278-7393.23.1.123 1:STN:280:DyaK2s7nvFOrtQ%3D%3D (Pubitemid 127541490)
35. EE Tanner-Smith 2006 Pharmacological content of tablets sold as "ecstasy": results from an online testing service Drug Alcohol Depend 83 3 247 254 16364567 10.1016/j.drugalcdep.2005.11.016 1:CAS:528: DC%2BD28Xmt1Oqsrg%3D
36. N Vogels TM Brunt, et al. 2009 Content of ecstasy in the Netherlands: 1993-2008 Addiction 104 12 2057 2066 19804461 10.1111/j.1360-0443.2009.02707.x
37. SN Young SE Smith, et al. 1985 Tryptophan depletion causes a rapid lowering of mood in normal males Psychopharmacology (Berl) 87 2 173 177 10.1007/BF00431803 1:CAS:528:DyaL2MXlsFyhtr8%3D (Pubitemid 16253342)
38. KK Zakzanis Z Campbell, et al. 2007 The neuropsychology of ecstasy (MDMA) use: a quantitative review Hum Psychopharmacol 22 7 427 435 17896346 10.1002/hup.873 1:CAS:528:DC%2BD2sXhtlSqu7nF (Pubitemid 47611297)
39. AS Zigmond RP Snaith 1983 The hospital anxiety and depression scale Acta Psychiatr Scand 67 6 361 370 6880820 10.1111/j.1600-0447.1983.tb09716.x 1:STN:280:DyaL3s3nvFWjug%3D%3D (Pubitemid 13098606)